Please login to the form below

Not currently logged in
Email:
Password:

Allegro

This page shows the latest Allegro news and features for those working in and with pharma, biotech and healthcare.

Ashfield wins gold at the UK Employee Experience Awards

Ashfield wins gold at the UK Employee Experience Awards

Fast-track for medical writers impresses judges. Ashfield Healthcare Communications has won gold for its medical writing training programme allegro at the UK Employee Experience Awards 2019. ... The allegro team attended the awards last week and took

Latest news

  • GCI Health expands into Asia, Lucid adds to Futures Academy and more GCI Health expands into Asia, Lucid adds to Futures Academy and more

    Ashfield’s medical writers graduate. Ashfield Healthcare Communications has seen its first cohort of medical writers graduate from training programme Allegro. ... The company plans to increase recruitment to Allegro this year, expanding the geographic

  • ROAD wins new account, Ark rebrands and Ashfield sees third intake of writers ROAD wins new account, Ark rebrands and Ashfield sees third intake of writers

    Ashfield’s Allegro welcomes third intake of medical writers. Following on the from the success of the first two intakes, 15 more employees joined the business as associate medical writers, and ... The Allegro programme has been designed to ensure

  • Ashfield welcomes second intake of medical writers Ashfield welcomes second intake of medical writers

    Neil Marmont, Allegro’s programme director, said: “The 15 associate medical writers who joined Allegro in January have all successful completed the eight-week training curriculum and are now delivering work ... Ashfield aims to train up to 80 writers

  • Multiplying options for MS

    Gilenya. In December 2010, top-line results from the pivotal phase III ALLEGRO trial were announced, indicating that the drug met its primary endpoint of reducing annualised relapse rates in patients ... Completion of this trial is expected later in 2011.

  • MS treatment hopes

    or placebo, and the similar, two-armed (laquinimod versus placebo) ALLEGRO trial.

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics